Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • API

    Tag: api

    You Searched For "API"
    Mylan to infuse USD 1 billion on capex in India

    Mylan to infuse USD 1 billion on capex in India

    Medical Dialogues Bureau30 Sept 2019 9:30 AM IST
    Mylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million...
    CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

    CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

    Meghna A Singhania27 Sept 2019 12:19 PM IST
    New Delhi : Taking into consideration, the proposal on measures need to be taken to address the issue of repacking of Active Pharmaceutical...
    Laurus Labs to acquire subsidiary of ASPEN Pharmacare

    Laurus Labs to acquire subsidiary of ASPEN Pharmacare

    Farhat Nasim24 Sept 2019 9:30 AM IST
    "The completion of conditions precedent, by way of cash consideration of ZAR 75,000, the Pharmaceutical company said in a statement here. The...
    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Medical Dialogues Bureau29 Aug 2019 4:10 PM IST
    New Delhi: The Drugs Technical Advisory Board (DTAB) has recently recommended for amendment of the Drugs and Cosmetics Rules, 1945 regarding...
    CDSCO preparing list of dual-use APIs imported from unregistered firms

    CDSCO preparing list of dual-use APIs imported from unregistered firms

    Medical Dialogues Bureau26 Aug 2019 2:23 PM IST
    "The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the...
    Natco Pharma gets 6 USFDA observations for API facility near Hyderabad

    Natco Pharma gets 6 USFDA observations for API facility near Hyderabad

    Medical Dialogues Bureau13 Aug 2019 1:16 PM IST
    Natco Pharma said it will provide due justifications and corrective action plan within the next 15 working days to address the USFDA observations.NEW...
    Shilpa Medicare gets 5 USFDA observations for Raichur facility

    Shilpa Medicare gets 5 USFDA observations for Raichur facility

    Medical Dialogues Bureau31 July 2019 9:30 AM IST
    "We have received Form 483 with five observations, with no repeat observations and any data integrity observations. The observations are mostly...
    Doctors should prescribe only generic medicines: CDSCO Committee

    Doctors should prescribe only generic medicines: CDSCO Committee

    Medical Dialogues Bureau23 July 2019 5:36 PM IST
    The generic medicines are at least 90 per cent cheaper than branded medicines. There are nearly 600 types of generic medicines and about 23 kinds of...
    USFDA completes inspection at Laurus Labs

    USFDA completes inspection at Laurus Labs' AP unit

    Medical Dialogues Bureau19 July 2019 10:02 AM IST
    Mumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
    Natco Pharma gets zero USFDA observations for Chennai facility

    Natco Pharma gets zero USFDA observations for Chennai facility

    Medical Dialogues Bureau16 July 2019 9:30 AM IST
    Natco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Medical Dialogues Bureau8 July 2019 1:32 PM IST
    As part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
    Piramal Pharma invests over Rs 69 crore to expand its API capability

    Piramal Pharma invests over Rs 69 crore to expand its API capability

    Medical Dialogues Bureau21 Jun 2019 10:00 AM IST
    The new wing at the Riverview site is dedicated to the production of HPAPIs with low occupational exposure levels (OELs), Piramal Pharma Solutions...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok